AJGP > Authors > Adel Ekladious

Authors

Adel Ekladious

FRCP, FRACP, Consultant Physician, Department of General Medicine and Acute Assessment Unit, Canberra Hospital, Canberra, ACT; Clinical Associate Professor, Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA; Associate Professor, ANU College of Health and Medicine, Australian National University, Canberra, ACT

Sodium–glucose cotransporter 2 inhibitors for chronic kidney disease: Why, when and when not

This article aims to provide evidence-based information to GPs, aiding the decision to initiate sodium–glucose cotransporter 2 (SGLT2) inhibitors for chronic kidney disease patients.

Australian Journal of General Practice (AJGP) is published by The Royal Australian College of General Practitioners, 100 Wellington Parade, East Melbourne, Victoria 3002, Australia

Email ajgp@racgp.org.au

The Royal Australian College of General Practitioners acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Custodians of the land and sea in which we live and work, we recognise their continuing connection to land, sea and culture and pay our respects to Elders past, present and future.

© 2024 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807